Document Detail

The role of everolimus-eluting and resolute zotarolimus-eluting stents in the treatment of coronary bifurcations.
MedLine Citation:
PMID:  23995715     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVES: To compare the long-term clinical outcomes of everolimus-eluting (EES) and Resolute zotarolimus-eluting (R-ZES) stents in the treatment of coronary bifurcation lesions.
BACKGROUND: Recent studies have suggested that the R-ZES is comparable to the EES in the treatment of de novo coronary artery disease. Available data on how these compare in the treatment of bifurcation lesions are limited.
METHODS: We retrospectively analyzed consecutive de novo bifurcation lesions, including left main stem lesions, treated with either EES or R-ZES between October 2006 and October 2011. Study endpoints examined included major adverse cardiac events (MACEs), defined as the composite of all-cause death, myocardial infarction (MI), including periprocedural MI, and target vessel revascularization (TVR). Target lesion revascularization (TLR) per patient and per bifurcation as well as stent thrombosis (ST) were also analyzed.
RESULTS: We identified 235 bifurcation lesions treated with either EES (157 lesions in 154 patients) or R-ZES (78 lesions in 73 patients). Baseline clinical and procedural characteristics were broadly similar between the two groups. No significant differences in MACE (14.6% vs 11.5%; P=.99) or TVR (8.0% vs 7.3%; P=.45) rates were noted between the two groups at 2-year follow-up. The incidence of ST was low and similar in both groups (0% vs 1.4%).
CONCLUSIONS: EES and R-ZES are associated with acceptable and comparable long-term clinical outcomes when used in the treatment of bifurcation lesions. Further evaluation into the role of currently available drug-eluting stents in bifurcation percutaneous coronary intervention is required.
Santo Ferrarello; Charis Costopoulos; Azeem Latib; Toru Naganuma; Alessandro Sticchi; Filippo Figini; Sandeep Basavarajaiah; Mauro Carlino; Alaide Chieffo; Matteo Montorfano; Masanori Kawaguchi; Charbel Naim; Francesco Giannini; Antonio Colombo
Related Documents :
20406325 - Mechanisms of the protective effects of bmscs promoted by tmdr with heparinized bfgf-in...
12039855 - The wilms' tumor suppressor wt1 is expressed in the coronary vasculature after myocardi...
20811105 - Fabrication and characterization of bio-engineered cardiac pseudo tissues.
9458875 - Altered k+ current of ventricular myocytes in rats with chronic myocardial infarction.
21999865 - Presence of extensive lv remodeling limits the benefits of crt in patients with intrave...
8538345 - Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of invasive cardiology     Volume:  25     ISSN:  1557-2501     ISO Abbreviation:  J Invasive Cardiol     Publication Date:  2013 Sep 
Date Detail:
Created Date:  2013-09-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8917477     Medline TA:  J Invasive Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  436-40     Citation Subset:  IM    
EMO-GVM Centro Cuore Columbus, 48 Via M. Buonarroti, 20145 Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Predictors of stent strut malapposition in calcified vessels using frequency-domain optical coherenc...
Next Document:  Estimating Incidence of Organ Cancer Related to PCI Radiation Exposure in Patients Treated For Acute...